Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition
暂无分享,去创建一个
N. Obuchowski | D. Margolis | T. Chenevert | A. Shukla-Dave | M. Boss | S. Punwani | A. Barnes | D. Malyarenko | Saurabh Singh | Harriet J. Rogers
[1] Daniel C. Alexander,et al. Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study. , 2022, Radiology.
[2] Adam T Froemming,et al. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG‐ACRIN Research Group (ACRIN 6701) , 2022, Journal of magnetic resonance imaging : JMRI.
[3] D. Margolis,et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. , 2019, European urology.
[4] David Atkinson,et al. VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient , 2019, Radiology.
[5] Prasad R. Shankar,et al. A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores. , 2019, AJR. American journal of roentgenology.
[6] Thomy Mertzanidou,et al. VERDICT MRI validation in fresh and fixed prostate specimens using patient‐specific moulds for histological and MR alignment , 2019, NMR in biomedicine.
[7] N. Obuchowski,et al. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trials , 2018, Journal of magnetic resonance imaging : JMRI.
[8] András Jakab,et al. Intra-voxel incoherent motion MRI of the living human foetus: technique and test–retest repeatability , 2017, European Radiology Experimental.
[9] Amy Kaczmarowski,et al. Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging , 2017, Journal of medical imaging.
[10] D. Koh,et al. Non-Mono-Exponential Analysis of Diffusion-Weighted Imaging for Treatment Monitoring in Prostate Cancer Bone Metastases , 2017, Scientific Reports.
[11] F. Fennessy,et al. Multiparametric Magnetic Resonance Imaging of the Prostate , 2017, Investigative radiology.
[12] M. Parmar,et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study , 2017, The Lancet.
[13] David Atkinson,et al. INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer , 2016, BMC Cancer.
[14] D. Collins,et al. Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort , 2016, European Radiology.
[15] B. Delahunt,et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.
[16] Bachir Taouli,et al. IVIM diffusion-weighted imaging of the liver at 3.0 T: Comparison with 1.5 T , 2015, European journal of radiology open.
[17] R. Gabe,et al. PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer☆ , 2015, Contemporary clinical trials.
[18] Mithat Gönen,et al. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment , 2015, Statistical methods in medical research.
[19] Aytekin Oto,et al. Apparent diffusion coefficient for prostate cancer imaging: impact of B values. , 2014, AJR. American journal of roentgenology.
[20] Celia P. Corona-Villalobos,et al. Agreement and Reproducibility of Apparent Diffusion Coefficient Measurements of Dual-b-Value and Multi-b-Value Diffusion-Weighted Magnetic Resonance Imaging at 1.5 Tesla in Phantom and in Soft Tissues of the Abdomen , 2013, Journal of computer assisted tomography.
[21] H. Huisman,et al. Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness. , 2012, Radiology.
[22] R. Boubertakh,et al. In vitro and in vivo repeatability of abdominal diffusion-weighted MRI. , 2012, The British journal of radiology.
[23] Namkug Kim,et al. Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.
[24] L. Turnbull,et al. Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T. , 2007, Magnetic resonance imaging.
[25] D. Le Bihan,et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.
[26] N. Obuchowski,et al. Quantitative imaging biomarkers: Effect of sample size and bias on confidence interval coverage , 2018, Statistical methods in medical research.
[27] H. Huisman,et al. Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging. , 2016, Radiology.
[28] D. Margolis,et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.